Chiropractors in Ely, MN Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Dr. Robert Mattson, DC CCSP Chiropractor - Sports Physician Medicare: Accepting Medicare Assignments Practice Location: 247 E Chapman St, Ely, MN 55731 Phone: 218-365-4111 |
 Ely Chiropractic Clinic Chiropractor - Sports Physician Medicare: Medicare Enrolled Practice Location: 247 E Chapman St, Ely, MN 55731 Phone: 218-365-4111 |
Roth Chiropractic Clinic Ltd Chiropractor - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 39 E Sheridan St, Ely, MN 55731 Phone: 218-365-5770 Fax: 218-365-5770 |
Dr. Lavern A Phelps Jr., D.C. Chiropractor - Neurology Medicare: Accepting Medicare Assignments Practice Location: 22 E Chapman St, Ely, MN 55731 Phone: 218-365-4044 Fax: 218-365-3249 |
Phelps Chiropractic P.a. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 22 E Chapman St, Ely, MN 55731 Phone: 218-365-4044 Fax: 218-365-4044 |
Dr. Lars Lyle Roth Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 39 E Sheridan, Ely, MN 55731 Phone: 218-365-5770 |
News Archive
European wireless patient monitoring devices market grown with rising awareness among ageing population
Lucrative opportunities await manufacturers in the European wireless patient monitoring devices market, particularly in the wireless assisted living devices segment. This segment is growing at a rapid pace. The primary reason for this growth is rising awareness levels among an ageing population about devices that help in attaining a better standard of life.
Study shows hypomethylation increases through progression of multiple myeloma
DNA methylation, a modification of DNA linked to gene regulation — is altered with increasing severity in a blood cancer called multiple myeloma, according to a study by Mayo Clinic and the Translational Genomics Research Institute (TGen).
McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
Impress your boss with this course
In this webinar, Dr. Michael W. Dong, Pittcon Short Course Instructor, will review best practices, short cuts, and tricks-of-the-trade to help pharmaceutical and other scientists to become more successful in developing effective HPLC methods (potency and ICH-compliant stability-indicating assays) using method templates and universal generic gradient methods.
BMA warns future doctors face training chaos
Under the government's 'Modernising Medical Careers' plans, from August 2005 the first two years of junior doctors' training are to be replaced with a 'foundation programme'. However, there is currently very little information about the content of the second year of the programmes, or how doctors' skills will be assessed.
› Verified 6 days ago